| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |